Pressure BioSciences
Gary Smejkal is a seasoned research scientist with extensive experience in proteomics and applications science. Currently serving as Senior Research Scientist at Pressure BioSciences, Inc. since February 2017, Gary has held key positions at various prestigious institutions, including Affiliate Assistant Professor at the University of New Hampshire and Chief Scientific Officer at Focus Proteomics LLC. Previous roles include Proteomics Scientist at Covaris and Harvard Medical School, as well as Visiting Scientist positions at Harvard School of Public Health and Politecnico di Milano. Gary's early career included significant contributions as a Senior Applications Scientist at Pressure BioSciences, Inc. and Proteome Systems, along with a foundational role as Research Scientist at the Cleveland Clinic Foundation's Lerner Research Institute.
This person is not in any teams
Pressure BioSciences
Pressure BioSciences Inc. (PBI) is a life sciences company focused on the development and commercialization of a novel, enabling, platform technology called pressure cycling technology ("PCT"). PCT uses cycles of hydrostatic pressure between ambient and ultra-high levels (up to 35,000 psi and greater) to control bio-molecular interactions.